BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/26/2026 10:19:30 AM | Browse: 137 | Download: 252
Publication Name World Journal of Gastrointestinal Surgery
Manuscript ID 114796
Country United States
ISSN 1948-9366 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Letter to the Editor
Article Title From inflammation to precision medicine in colon cancer: Methodological considerations and future directions
Manuscript Source Invited Manuscript
All Author List Arunkumar Krishnan
ORCID
Author(s) ORCID Number
Arunkumar Krishnan http://orcid.org/0000-0002-9452-7377
Funding Agency and Grant Number
Corresponding Author Arunkumar Krishnan, Assistant Professor, MD, Senior Scientist, Department of Oncology, Atrium Health Levine Cancer, 1021 Morehead Medical Drive, Charlotte, NC 28204, United States. dr.arunkumar.krishnan@gmail.com
Key Words Colon cancer; Elderly; Precision medicine; Systemic immune-inflammation index; Lactoferrin; Prognostic biomarkers; Survival; Methodological critique
Core Tip A study by Zhu SS et al reported that the systemic immune-inflammation index and serum lactoferrin levels predict survival in elderly patients with colon cancer. While promising, the study was limited by a small, single-center cohort, a short follow-up period, and an incomplete adjustment for confounders. Predictive accuracy was only moderate, yet conclusions were overstated. To ensure clinical utility, future research should validate systemic immune-inflammation index and lactoferrin in larger, multicenter studies with longer follow-up, benchmark them against established prognostic indices, and incorporate molecular markers. Such efforts are crucial to establishing reliable, externally validated prognostic tools for the individualized management of older colon cancer patients.
Publish Date 2026-02-26 10:19
Citation

Krishnan A. From inflammation to precision medicine in colon cancer: Methodological considerations and future directions. World J Gastrointest Surg 2026; 18(2): 114796

URL https://www.wjgnet.com/1948-9366/full/v18/i2/114796.htm
DOI https://dx.doi.org/10.4240/wjgs.v18.i2.114796
Full Article (PDF) WJGS-18-114796-with-cover.pdf